WNT1 and breast adenocarcinoma: Transgenic expression of Wnt1 using a mouse mammary tumor virus LTR enhancer causes extensive ductal hyperplasia early in life and mammary adenocarcinomas in approximately 50% of the female transgenic (MMTV-Wnt1) mice by 6 months of age (24).